Access cutting-edge rheumatoid arthritis treatment through this clinical trial at a research site in Tuscaloosa. Study-provided care at no cost to qualified participants.
Access rheumatoid arthritis specialists in Tuscaloosa at no cost
This study follows strict safety protocols and ethical guidelines
All study-related rheumatoid arthritis treatment provided free
A Basket Trial of Refractory Rheumatoid Arthritis (RA), Sjögren's Disease (SjD), Idiopathic Inflammatory Myopathies (IIMs) and Systemic Sclerosis (SSc) subjects to evaluate the safety and efficacy of AlloNK, a non-genetically modified allogeneic NK cell, in combination with rituximab.
Sponsor: Artiva Biotherapeutics, Inc.
Check if you qualify for this rheumatoid arthritis clinical trial in Tuscaloosa, AL
If you're searching for rheumatoid arthritis treatment options in Tuscaloosa, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tuscaloosa research site is actively enrolling participants for this clinical trial. You'll receive care from experienced rheumatoid arthritis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.